Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss von Everly, M. J., Everly, J. J., Arend, L. J., Brailey, P., Susskind, B., Govil, A., Rike, A., Roy‐Chaudhury, P., Mogilishetty, G., Alloway, R. R., Tevar, A., Woodle, E. S.

Volltext

The Value of Protocol Biopsies to Identify Patients With De Novo Donor‐Specific Antibody at High Risk for Allograft Loss von Schinstock, C. A., Cosio, F., Cheungpasitporn, W., Dadhania, D. M., Everly, M. J., Samaniego‐Picota, M. D., Cornell, L., Stegall, M. D.

Volltext

Examining abiotic and biotic factors influencing specimen black oaks (Quercus kelloggii) in northern California to reimplement traditional ecological knowledge and promote ecosyste... von O'Gorman, Cory J., Bentley, Lisa Patrick, McKay, Clint, Purser, Margaret, Everly, Kylie M.

Volltext

Proteasome Inhibition Reduces Donor-Specific Antibody Levels von Everly, M.J, Everly, J.J, Susskind, B, Brailey, P, Arend, L.J, Alloway, R.R, Roy-Chaudhury, P, Govil, A, Mogilishetty, G, Rike, A.H, Cardi, M, Wadih, G, Brown, E, Tevar, A, Woodle, E.S

Volltext

Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction von Dieplinger, G., Everly, M.J., Briley, K.P., Haisch, C.E., Bolin, P., Maldonado, A.Q., Kendrick, W.T., Kendrick, S.A., Morgan, C., Terasaki, P.I., Rebellato, L.M.

Volltext

Impact of the Presence and Duration of Donor-Specific Antibodies on Renal Function von Hoshino, J, Everly, M.J, Kaneku, H, Ubara, Y, Takaichi, K, Terasaki, P.I

Volltext

Bienestar psicológico y estrategias de afrontamiento en estudiantes de educación superior en tiempos de pandemia von García De la Ossa, Everly M., Ramos Monsivais, Cynthia Lizeth

Volltext

The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes von Freitas, Maria Cecilia S, Rebellato, Lorita M, Ozawa, Miyuki, Nguyen, Anh, Sasaki, Nori, Everly, Matthew, Briley, Kimberly P, Haisch, Carl E, Bolin, Paul, Parker, Karen, Kendrick, William T, Kendrick, Scott A, Harland, Robert C, Terasaki, Paul I

Volltext

Bortezomib Provides Effective Therapy for Antibody-and Cell-Mediated Acute Rejection von EVERLY, Matthew J, EVERLY, Jason J, CARDI, Michael, WADIH, George, TEVAR, Amit, WOODIE, E. Steve, SUSSKIND, Brian, BRAILEY, Paul, ARENA, Lois J, ALLOWAY, Rita R, ROY-CHAUDHURY, Prabir, GOVIL, Amit, MOGILISHETTY, Gautham, RIKE, Adele H

Volltext

Incidence and impact of de novo donor-specific alloantibody in primary renal allografts von Everly, Matthew J, Rebellato, Lorita M, Haisch, Carl E, Ozawa, Miyuki, Parker, Karen, Briley, Kimberly P, Catrou, Paul G, Bolin, Paul, Kendrick, William T, Kendrick, Scott A, Harland, Robert C, Terasaki, Paul I

Volltext

Characterization of the Chloroplast Cytochrome b6f Complex as a Structural and Functional Dimer von Huang, D, Everly, R. M, Cheng, R. H, Heymann, J. B, Schaegger, H, Sled, V, Ohnishi, T, Baker, T. S, Cramer, W. A

Volltext

HLA-Specific Antibodies Developed in the First Year Posttransplant are Predictive of Chronic Rejection and Renal Graft Loss von LEE, Po-Chang, LAN ZHU, TERASAKI, Paul I, EVERLY, Matthew J

Volltext

Posttransplant Lymphoproliferative Disorder von Everly, Matthew J, Bloom, Roy D, Tsai, Donald E, Trofe, Jennifer

Volltext

Therapeutic Endpoints in a Preemtive DSA Treatment Protocol with Bortezomib: 1958 von Everly, M., Terasaki, P. I., Trivedi, H. L.

Volltext

Therapeutic Endpoints in a Preemtive DSA Treatment Protocol with Bortezomib: 1958 von Everly, M., Terasaki, P. I., Trivedi, H. L.

Volltext

BORTEZOMIB EFFECTIVENESS IN 69 PATIENTS TREATED IN 29 CENTERS WORLDWIDE: 1046 von Everly, M. J., Terasaki, P. I.

Volltext

Abrogation of Anti-HLA Antibodies via Proteasome Inhibition von TRIVEDI, Hargovind L, TERASAKI, Paul I, KHEMCHANDANI, Sajani I, DAVE, Shruti D, FEROZ, Aziz, EVERLY, Matthew J, VANIKAR, Aruna V, SHANKAR, Vangipurapu, TRIVEDI, Varsha B, KANEKU, Hugo, IDICA, Adam K, MODI, Pranjal R

Volltext

Selective Depletion of Complement-Binding Anti-HLA Antibodies Following BLyS Neutralization with Belimumab: Abstract# B3028 von Kamoun, M., Trofe-Clark, J., Migone, T., Kearns, J., Everly, M., Terasaki, P., Prak, Luning E., Abt, P., Naji, A.

Volltext

Novel translocation in acute megakaryoblastic leukemia (AML-M7) von TORETSKY, Jeffrey A, EVERLY, Eileen M, PADILLA-NASH, Hesed M, CHEN, Allen, ABRUZZO, Lynne V, ESKENAZI, Allen E, FRANTZ, Chris, RIED, Thomas, STAMBERG, Judith

Volltext

Incidence and Impact of Anti-HLA-DP-Antibodies in Renal Transplantation: Abstract# 724 von Hoermann, M., Rebellato, L., Everly, M., Reyes, N., Dieplinger, G., Maldonado, A., Briley, K., Bolin, P., Kendrick, W., Kendrick, S., Morgan, C., Haisch, C., Harland, R., Terasaki, P.

Volltext